ASPH and neoplasm: To investigate a possible contribution of ASPH inhibition to cancer immunotherapy, we selected the mouse TC-1/A9 tumor model, which exhibits a low sensitivity to DNA vaccination alone, but tumor growth was significantly reduced after combined immunotherapy with a DNA vaccine and the synthetic oligonucleotide ODN182652 carrying immunostimulatory CpG motifs.